Søgeresultater - Rihawi, Karim
- Showing 1 - 17 results of 17
-
1
-
2
-
3
-
4
Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines? af Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Minisini, Alessandro Marco, Rihawi, Karim, Fasola, Gianpiero, Puglisi, Fabio
Udgivet 2015Text -
5
Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Mana... af Khan, Khurum H., Wong, Mabel, Rihawi, Karim, Bodla, Shankar, Morganstein, Daniel, Banerji, Udai, Molife, Lulama R.
Udgivet 2016Text -
6
-
7
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example af Gerratana, Lorenzo, De Maglio, Giovanna, De Pellegrin, Alessandro, Follador, Alessandro, Rihawi, Karim, Pizzolitto, Stefano, Puglisi, Fabio, Fasola, Gianpiero
Udgivet 2016Text -
8
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies af Gelfo, Valerio, Romaniello, Donatella, Mazzeschi, Martina, Sgarzi, Michela, Grilli, Giada, Morselli, Alessandra, Manzan, Beatrice, Rihawi, Karim, Lauriola, Mattia
Udgivet 2020Text -
9
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study af Ricci, Costantino, Capizzi, Elisa, Giunchi, Francesca, Casolari, Laura, Gelsomino, Francesco, Rihawi, Karim, Natali, Filippo, Livi, Vanina, Trisolini, Rocco, Fiorentino, Michelangelo, Ardizzoni, Andrea
Udgivet 2020Text -
10
Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications af Rihawi, Karim, Ricci, Angela Dalia, Rizzo, Alessandro, Brocchi, Stefano, Marasco, Giovanni, Pastore, Luigi Vincenzo, Llimpe, Fabiola Lorena Rojas, Golfieri, Rita, Renzulli, Matteo
Udgivet 2021Text -
11
Higher risk of infections with PI3K-AKT-mTOR pathway inhibitors in patients with advanced solid tumors on Phase I clinical trials af Rafii, Saeed, Roda, Desamparados, Geuna, Elena, Jimenez, Begona, Rihawi, Karim, Capelan, Marta, Yap, Timothy A, Molife, L Rhoda, Kaye, Stanley B, de Bono, Johann S, Banerji, Udai
Udgivet 2015Text -
12
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report()() af Rihawi, Karim, Alfieri, Roberta, Fiorentino, Michelangelo, Fontana, Francesca, Capizzi, Elisa, Cavazzoni, Andrea, Terracciano, Mario, La Monica, Silvia, Ferrarini, Alberto, Buson, Genny, Petronini, Pier Giorgio, Ardizzoni, Andrea
Udgivet 2018Text -
13
HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives af Fanotto, Valentina, Ongaro, Elena, Rihawi, Karim, Avallone, Antonio, Silvestris, Nicola, Fornaro, Lorenzo, Vasile, Enrico, Antonuzzo, Lorenzo, Leone, Francesco, Rosati, Gerardo, Giuliani, Francesco, Bordonaro, Roberto, Scartozzi, Mario, Maglio, Giovanna De, Negri, Francesca V., Fasola, Gianpiero, Aprile, Giuseppe
Udgivet 2016Text -
14
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer af Mazzeschi, Martina, Sgarzi, Michela, Romaniello, Donatella, Gelfo, Valerio, Cavallo, Carola, Ambrosi, Francesca, Morselli, Alessandra, Miano, Carmen, Laprovitera, Noemi, Girone, Cinzia, Ferracin, Manuela, Santi, Spartaco, Rihawi, Karim, Ardizzoni, Andrea, Fiorentino, Michelangelo, D’Uva, Gabriele, Győrffy, Balázs, Palmer, Ruth, Lauriola, Mattia
Udgivet 2022Text -
15
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products af Ferrarini, Alberto, Forcato, Claudio, Buson, Genny, Tononi, Paola, del Monaco, Valentina, Terracciano, Mario, Bolognesi, Chiara, Fontana, Francesca, Medoro, Gianni, Neves, Rui, Möhlendick, Birte, Rihawi, Karim, Ardizzoni, Andrea, Sumanasuriya, Semini, Flohr, Penny, Lambros, Maryou, de Bono, Johann, Stoecklein, Nikolas H., Manaresi, Nicolò
Udgivet 2018Text -
16
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer af Filitto, Giuseppe, Coppola, Francesca, Curti, Nico, Giampieri, Enrico, Dall’Olio, Daniele, Merlotti, Alessandra, Cattabriga, Arrigo, Cocozza, Maria Adriana, Taninokuchi Tomassoni, Makoto, Remondini, Daniel, Pierotti, Luisa, Strigari, Lidia, Cuicchi, Dajana, Guido, Alessandra, Rihawi, Karim, D’Errico, Antonietta, Di Fabio, Francesca, Poggioli, Gilberto, Morganti, Alessio Giuseppe, Ricciardiello, Luigi, Golfieri, Rita, Castellani, Gastone
Udgivet 2022Text -
17
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours af de Bono, Johann, Lin, Chia-Chi, Chen, Li-Tzong, Corral, Jesus, Michalarea, Vasiliki, Rihawi, Karim, Ong, Michael, Lee, Jih-Hsiang, Hsu, Chih-Hung, Yang, James Chih-Hsin, Shiah, Her-Shyong, Yen, Chia-Jui, Anthoney, Alan, Jove, Maria, Buschke, Susanne, Fuertig, René, Schmid, Ulrike, Goeldner, Rainer-Georg, Strelkowa, Natalja, Huang, Dennis Chin-Lun, Bogenrieder, Thomas, Twelves, Chris, Cheng, Ann-Lii
Udgivet 2020Text